Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Fairlie

Showing results (101-110 of 326) with videos related to

Pageof 33
Sort By:
Analytical Biochemistry|March 4, 2008
A dual-purpose synthetic colloidal platform for protease mapping: substrate profiling for Dengue and West Nile virus proteasesLionel Marcon, Darby Kozak, Bronwyn J Battersby, et al.
Plos One|March 3, 2012
Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitorsKatherine T Andrews, Archna P Gupta, Thanh N Tran, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2012
C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signalingJunxian Lim, Abishek Iyer, Jacky Y Suen, et al.
Journal of Medicinal Chemistry|December 4, 2014
Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulenceWilko Duprez, Lakshmanane Premkumar, Maria A Halili, et al.
RSC Chemical Biology|July 22, 2022
Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptakeAline D de Araujo, Junxian Lim, Kai-Chen Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel diseaseTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 9, 2013
Rv2969c, essential for optimal growth in Mycobacterium tuberculosis, is a DsbA-like enzyme that interacts with VKOR-derived peptides and has atypical features of DsbA-like disulfide oxidasesLakshmanane Premkumar, Begoña Heras, Wilko Duprez, et al.
Chemical Communications (Cambridge, England)|October 22, 2019
Mirror image pairs of cyclic hexapeptides have different oral bioavailabilities and metabolic stabilitiesRink-Jan Lohman, Daniel S Nielsen, W Mei Kok, et al.
Molecular and Cellular Endocrinology|January 9, 2014
C5aR and C5L2 act in concert to balance immunometabolism in adipose tissuePegah Poursharifi, Marc Lapointe, Alexandre Fisette, et al.
Plos One|July 31, 2015
Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbAWilko Duprez, Prabhakar Bachu, Martin J Stoermer, et al.
Pageof 33

Showing results (101-110 of 326) with videos related to

Sort By:
Pageof 33
Analytical Biochemistry|March 4, 2008
A dual-purpose synthetic colloidal platform for protease mapping: substrate profiling for Dengue and West Nile virus proteasesLionel Marcon, Darby Kozak, Bronwyn J Battersby, et al.
Plos One|March 3, 2012
Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitorsKatherine T Andrews, Archna P Gupta, Thanh N Tran, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2012
C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signalingJunxian Lim, Abishek Iyer, Jacky Y Suen, et al.
Journal of Medicinal Chemistry|December 4, 2014
Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulenceWilko Duprez, Lakshmanane Premkumar, Maria A Halili, et al.
RSC Chemical Biology|July 22, 2022
Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptakeAline D de Araujo, Junxian Lim, Kai-Chen Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel diseaseTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 9, 2013
Rv2969c, essential for optimal growth in Mycobacterium tuberculosis, is a DsbA-like enzyme that interacts with VKOR-derived peptides and has atypical features of DsbA-like disulfide oxidasesLakshmanane Premkumar, Begoña Heras, Wilko Duprez, et al.
Chemical Communications (Cambridge, England)|October 22, 2019
Mirror image pairs of cyclic hexapeptides have different oral bioavailabilities and metabolic stabilitiesRink-Jan Lohman, Daniel S Nielsen, W Mei Kok, et al.
Molecular and Cellular Endocrinology|January 9, 2014
C5aR and C5L2 act in concert to balance immunometabolism in adipose tissuePegah Poursharifi, Marc Lapointe, Alexandre Fisette, et al.
Plos One|July 31, 2015
Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbAWilko Duprez, Prabhakar Bachu, Martin J Stoermer, et al.
Pageof 33